See every side of every news story
Published loading...Updated

Elizabeth Holmes' Partner Pursues New Blood-Testing Venture Echoing Theranos

  • As of May 2025, Billy Evans, who is in a relationship with Elizabeth Holmes—the imprisoned founder of Theranos—is heading a new U.S.-based startup named Haemanthus.
  • Evans started Haemanthus to provide disease detection through a device analyzing blood, saliva, and urine that echoes the ambitious promises of Theranos, whose fraud led to Holmes' 11-year prison sentence.
  • Haemanthus markets itself as offering a radically new diagnostic approach, aims to begin with pet health testing before expanding to humans, and plans to raise over $50 million for development.
  • Investor Jim Breyer declined to fund Haemanthus, citing concerns similar to those that made his team twice pass on Theranos, while marketing materials call the company “the future of diagnostics.”
  • The development of Haemanthus suggests continued investor interest in blood-testing innovation despite Holmes’ fraud conviction, but launch timing remains uncertain and skepticism persists.
Insights by Ground AI
Does this summary seem wrong?

30 Articles

All
Left
13
Center
4
Right
4
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 62% of the sources lean Left
62% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

npr broke the news in Washington, United States on Saturday, May 10, 2025.
Sources are mostly out of (0)